CIK 0001159036
HALO HALOZYME THERAPEUTICS, INC.
Insider trading from SEC Form 4. Last filing 2 d ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
4
with a Form 4 at this company
Signals
Open-market buys and sells at HALOZYME THERAPEUTICS, INC., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 10Weak | sell10b5-1 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | $1.1M | 20,000 | -11% | - |
Congressional trades
2 trades in HALO disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | HALO Halozyme Therapeutics, Inc. - Common Stock | $1,001 to $15k | Mar 9, 2026 | 29 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Partial sale | HALO Halozyme Therapeutics, Inc. - Common Stock | $1,001 to $15k | Mar 24, 2025 | 14 days after the trade |
Transactions
The last 12 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 5, 2026 | Connaughton Bernadette director | AGrant or award Common Stock | +3,796 | $0.00 | $0 | 42,294 | 2 d ago |
| Nov 29, 2024 | Torley Helen PRESIDENT AND CEO | GGift Common Stock | -10,000 | $0.00 | $0 | 666,744 | Dec 3, 2024 |
| Nov 29, 2024 | MATSUI CONNIE director | GGift Common Stock | -10,470 | $0.00 | $0 | 183,035 | Dec 3, 2024 |
| Oct 15, 2024 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | MOption exercise Common Stock10b5-1 | +5,509 | $16.65 | $92k | 179,265 | Oct 16, 2024 |
| Oct 15, 2024 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | MOption exercise Common Stock10b5-1 | +4,491 | $19.98 | $90k | 183,756 | Oct 16, 2024 |
| Oct 15, 2024 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | SOpen-market sale Common Stock10b5-1 | -9,923 | $53.74 | $533k | 173,833 | Oct 16, 2024 |
| Oct 15, 2024 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | SOpen-market sale Common Stock10b5-1 | -77 | $54.25 | $4,177 | 173,756 | Oct 16, 2024 |
| Oct 16, 2024 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | MOption exercise Common Stock10b5-1 | +10,000 | $19.98 | $200k | 183,756 | Oct 16, 2024 |
| Oct 16, 2024 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | SOpen-market sale Common Stock10b5-1 | -10,000 | $53.26 | $533k | 173,756 | Oct 16, 2024 |
| Oct 15, 2024 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | MOption exercise Option to Purchase Common Stockderivative10b5-1 | -5,509 | $0.00 | $0 | 6,352 | Oct 16, 2024 |
| Oct 15, 2024 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | MOption exercise Option to Purchase Common Stockderivative10b5-1 | -4,491 | $0.00 | $0 | 36,608 | Oct 16, 2024 |
| Oct 16, 2024 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | MOption exercise Option to Purchase Common Stockderivative10b5-1 | -10,000 | $0.00 | $0 | 26,608 | Oct 16, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Connaughton Bernadettedirector
- LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER
- MATSUI CONNIEdirector
- Torley HelenPRESIDENT AND CEO
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.